Your search returned 21 results.

Sort
Results
1.
Pazopanib for the treatment of breast cancer. [Review] MedStar authors:
  • Swain, Sandra M
PMID:
  • 22233389
Year: 2012
Citation:
  • Expert Opinion on Investigational Drugs. 21(2):217-25, 2012 Feb.
Institution:
  • Washington Cancer Institute
Medline publication type:
  • Journal Article
  • Research Support, N.I.H., Extramural
  • Review
Form of publication:
  • Journal Article
All authors:
  • Amiri-Kordestani L, Swain SM, Tan AR
2.
Pertuzumab : evolving therapeutic strategies in the management of HER2-overexpressing breast cancer. [Review] MedStar authors:
  • Swain, Sandra M
PMID:
  • 23530718
Year: 2013
Citation:
  • Expert Opinion on Biological Therapy. 13(5):779-90, 2013 May.
Institution:
  • Washington Cancer Institute
Medline publication type:
  • Journal Article
  • Research Support, Non-U.S. Gov't
  • Review
Form of publication:
  • Journal Article
All authors:
  • O'Sullivan CC, Swain SM
3.
Assessing the discordance rate between local and central HER2 testing in women with locally determined HER2-negative breast cancer. MedStar authors:
  • Swain, Sandra M
PMID:
  • 24930388
Year: 2014
Citation:
  • Cancer. 120(17):2657-64, 2014 Sep 1.
Institution:
  • Washington Cancer Institute
Medline publication type:
  • Comparative Study
  • Journal Article
  • Multicenter Study
  • Observational Study
  • Research Support, Non-U.S. Gov't
Form of publication:
  • Journal Article
All authors:
  • Bloom KJ, Brammer MG, Burris H, Chau M, Gralow JR, Kaufman PA, Lalla D, Mayer M, Pegram M, Rugo HS, Swain SM, Vogel CL, Yardley DA, Yoo B
4.
The SystHERs registry: an observational cohort study of treatment patterns and outcomes in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer. MedStar authors:
  • Swain, Sandra M
PMID:
  • 24885258
Year: 2014
Citation:
  • BMC Cancer. 14:307, 2014.
Institution:
  • Washington Cancer Institute
Medline publication type:
  • Clinical Trial
  • Journal Article
  • Research Support, Non-U.S. Gov't
Form of publication:
  • Journal Article
All authors:
  • Beattie M, Hurvitz S, Jahanzeb M, Kaufman PA, Lai C, Masaquel A, Mason G, O'Shaughnessy J, Rugo HS, Swain S, Tripathy D, Yoo B
5.
Intrinsic subtypes, PIK3CA mutation, and the degree of benefit from adjuvant trastuzumab in the NSABP B-31 trial. MedStar authors:
  • Swain, Sandra M
PMID:
  • 25559813
Year: 2015
Citation:
  • Journal of Clinical Oncology. 33(12):1340-7, 2015 Apr 20.
Institution:
  • Washington Cancer Institute
Medline publication type:
  • Journal Article
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
Form of publication:
  • Journal Article
All authors:
  • Blackmon NL, Costantino JP, Fehrenbacher L, Finnigan M, Gavin PG, Geyer CE Jr, Jeong JH, Kim SR, Mamounas EP, Paik S, Pogue-Geile KL, Rastogi P, Song N, Swain SM, Wickerham DL, Wolmark N
6.
Deleterious BRCA1/2 mutations in an urban population of Black women. MedStar authors:
  • Fries, Melissa
  • Lynce, Filipa
PMID:
  • 26250392
Year: 2015
Citation:
  • Breast Cancer Research & Treatment. 153(1):201-9, 2015 Aug.
Institution:
  • Washington Cancer Institute
Medline publication type:
  • Journal Article
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
Form of publication:
  • Journal Article
All authors:
  • DeMarco T, Fries M, Isaacs C, Lynce F, Peshkin BN, Smith KL, Stein J, Wang H, Wang Y
7.
Quantitative Gene Expression by Recurrence Score in ER-Positive Breast Cancer, by Age. MedStar authors:
  • Nunes, Raquel
  • Swain, Sandra M
PMID:
  • 26610382
Year: 2015
Citation:
  • Advances in Therapy. 32(12):1222-36, 2015 Dec.
Institution:
  • Washington Cancer Institute
Medline publication type:
  • Journal Article
  • Research Support, Non-U.S. Gov't
Form of publication:
  • Journal Article
All authors:
  • Nunes R, Rothney M, Sing AP, Swain SM, Yoshizawa C
8.
Cardiac function in BRCA1/2 mutation carriers with history of breast cancer treated with anthracyclines. MedStar authors:
  • Asch, Federico M
  • Barac, Ana
  • Herbolsheimer, Pia M
  • Lynce, Filipa
  • Mete, Mihriye
  • Nunes, Raquel
  • Shara, Nawar M
  • Swain, Sandra M
  • Wray, Lynette
PMID:
  • 26749359
Year: 2016
Citation:
  • Breast Cancer Research & Treatment. 155(2):285-93, 2016 Jan.
Institution:
  • MedStar Health Research Institute
  • MedStar Health Research Institute
  • MedStar Health Research Institute
  • MedStar Washington Hospital Center
  • MedStar Washington Hospital Center
  • Washington Cancer Institute
  • Washington Cancer Institute
  • Washington Cancer Institute A
  • Washington Cancer Instituteia
Department:
  • MedStar Heart Institute
  • MedStar Heart Institute
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Asch FM, Barac A, Herbolsheimer P, Isaacs C, Lynce F, Mete M, Nardacci MP, Nunes RA, Peshkin BN, Shara NM, Smith KL, Swain SM, Warren R, Wray L
9.
Association of Polymorphisms in FCGR2A and FCGR3A With Degree of Trastuzumab Benefit in the Adjuvant Treatment of ERBB2/HER2-Positive Breast Cancer: Analysis of the NSABP B-31 Trial. MedStar authors:
  • Swain, Sandra M
PMID:
  • 27812689
Year: 2017
Citation:
  • JAMA Oncology. 3(3):335-341, 2017 Mar 01
Institution:
  • Washington Cancer Institute
Medline publication type:
  • Clinical Trial, Phase III
  • Journal Article
  • Multicenter Study
  • Randomized Controlled Trial
Form of publication:
  • Journal Article
All authors:
  • Bandos H, Costantino JP, Fehrenbacher L, Finnigan M, Gavin PG, Geyer CE Jr, Jeong JH, Johnson NL, Kim SR, Lipchik C, Mamounas EP, Paik S, Pogue-Geile KL, Rastogi P, Song N, Swain SM, Wickerham DL, Wolmark N
10.
The effect of genetic variants on the relationship between statins and breast cancer in postmenopausal women in the Women's Health Initiative observational study. MedStar authors:
  • Howard, Barbara V
PMID:
  • 29063981
Year: 2018
Citation:
  • Breast Cancer Research & Treatment. 167(3):741-749, 2018 02.
Institution:
  • MedStar Health Research Institute
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Beebe-Dimmer JL, Bock CH, Cote ML, Desai P, Dyson G, Hou L, Howard BV, Jay AM, Prentice R, Purrington K, Simon MS
11.
SAFE-HEaRt: Rationale and Design of a Pilot Study Investigating Cardiac Safety of HER2 Targeted Therapy in Patients with HER2-Positive Breast Cancer and Reduced Left Ventricular Function. MedStar authors:
  • Asch, Federico M
  • Barac, Ana
  • Lynce, Filipa
  • Swain, Sandra M
PMID:
  • 28314836
Year: 2017
Citation:
  • Oncologist. 22(5):518-525, 2017 May
Institution:
  • MedStar Heart & Vascular Institute
  • Washington Cancer Institute
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Asch FM, Barac A, Dang C, Isaacs C, Lynce F, Smith KL, Swain SM, Tan MT
12.
Avoiding over- and undertreatment in patients with resected node-positive breast cancer with the use of gene expression signatures: are we there yet?. [Review] MedStar authors:
  • Swain, Sandra
PMID:
  • 31131397
Year: 2019
Citation:
  • Annals of Oncology. 30(7):1044-1050, 2019 07 01.
Institution:
  • MedStar Health
Department:
  • Associate Dean for Research Development
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Bergh J, Foukakis T, Matikas A, Swain S
13.
Toward a Better Understanding of the Differential Impact of Heart Failure Phenotypes After Breast Cancer. MedStar authors:
  • Barac, Ana
PMID:
  • 35687827
Year: 2022
Citation:
  • Journal of Clinical Oncology. 40(32):3688-3691, 2022 Nov 10.
Institution:
  • MedStar Heart & Vascular Institute
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Barac A, Cheng RK, Hovsepyan G, Reding KW, Simon MS, Stefanick M, Vasbinder A
14.
NSABP B-41, a Randomized Neoadjuvant Trial: Genes and Signatures Associated with Pathologic Complete Response. MedStar authors:
  • Swain, Sandra M
PMID:
  • 32371537
Year: 2020
Citation:
  • Clinical Cancer Research. 26(16):4233-4241, 2020 08 15.
Institution:
  • MedStar Health
Department:
  • Associate Dean for Research Development
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Bandos H, Brauer HA, Geyer CE Jr, Goerlitz DS, Harris BT, Lucas PC, Mamounas EP, Rastogi P, Ren Y, Robidoux A, Swain SM, Tang G, Wolmark N
15.
BRCA1/2 mutations and risk-reducing bilateral salpingo-oophorectomy among Latinas: The UPTAKE study. MedStar authors:
  • Lynce, Filipa
  • Schlam, Ilana
PMID:
  • 33010199
Year: 2021
Citation:
  • Journal of Genetic Counseling. 30(2):383-393, 2021 04.
Institution:
  • Washington Cancer Institute
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Ahn J, Campos C, Denduluri N, Dutil J, Friedman S, Geng X, Graves KD, Isaacs C, Lynce F, Nahleh Z, Peshkin BN, Ricker C, Rodriguez P, Schlam I
16.
Hematologic safety of palbociclib in combination with endocrine therapy in patients with benign ethnic neutropenia and advanced breast cancer. MedStar authors:
  • Blackburn, Matthew J
  • Chitalia, Ami
  • Dilawari, Asma
  • Gallagher, Christopher
  • Lynce, Filipa
  • Mohebtash, Mahsa
  • Tiwari, Shruti R
PMID:
  • 34157782
Year: 2021
Citation:
  • Cancer. 127(19):3622-3630, 2021 10 01.
Institution:
  • MedStar Franklin Square Cancer Center at Loch Raven Campus
  • MedStar Washington Hospital Center
  • Washington Cancer Institute
Department:
  • Hematology & Oncology Fellowship
  • Hematology and Oncology
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Abu-Khalaf M, Blackburn MJ, Chitalia A, Dilawari A, Gallagher C, Hahn OM, Isaacs C, Lynce F, Mohebtash M, Pohlmann PR, Shajahan-Haq AN, Tan M, Tiwari SR, Warren R, Wu T, Zhuo R
17.
Genomic profiling of breast cancer in African-American women using MammaPrint. MedStar authors:
  • Boisvert, Marc E
  • Herbolsheimer, Pia M
  • Mete, Mihriye
  • Nunes, Raquel
  • Swain, Sandra M
  • Wray, Lynette
PMID:
  • 27568021
Year: 2016
Citation:
  • Breast Cancer Research & Treatment. 159(3):481-8, 2016 Oct
Institution:
  • MedStar Health Research Institute
  • Washington Cancer Institute
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Bijelic L, Boisvert ME, Herbolsheimer P, Mete M, Nunes RA, Smith KL, Swain SM, Wray L
18.
Breast cancer knowledge in Lebanese females with positive family history. MedStar authors:
  • El Maouchi, Paul
PMID:
  • 36800620
Year: 2023
Citation:
  • Medicine. 102(7):e32973, 2023 Feb 17.
Institution:
  • MedStar Union Memorial Hospital
Department:
  • Internal Medicine Residency
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • El Maouchi P, Fakhreddine O, Shmoury AH, El Zoghbi M, Chamseddine N, Abou Zeidane R, Amhaz G, Charafeddine M, Kazarian H, Assi HI
19.
Cultural adaptations to a telephone genetic counseling protocol and booklet for Latina breast cancer survivors at risk for hereditary breast and ovarian cancer. MedStar authors:
  • Alzamora, Maria
PMID:
  • 36694918
Year: 2023
Citation:
  • Translational Behavioral Medicine. 13(5):297-308, 2023 05 13.
  • Translational Behavioral Medicine. 13(5):297-308, 2023 May 13.
Institution:
  • MedStar Washington Hospital Center
Department:
  • Obstetrics & Gynecology Residency
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Gomez-Trillos S Graves KD Fiallos K Schwartz MD Peshkin BN Hamilton H Sheppard VB Vadaparampil ST Campos C Cupertino AP Alzamora MC Lynce F Hurtado-de-Mendoza A
20.
Patient-Reported Outcomes in OlympiA: A Phase III, Randomized, Placebo-Controlled Trial of Adjuvant Olaparib in gBRCA1/2 Mutations and High-Risk Human Epidermal Growth Factor Receptor 2-Negative Early Breast Cancer. MedStar authors:
  • McCarron, Edward C
PMID:
  • 38301187
Year: 2024
Citation:
  • Journal of Clinical Oncology. 42(11):1288-1300, 2024 Apr 10.
Institution:
  • MedStar Franklin Square Medical Center
Medline publication type:
  • Clinical Trial, Phase III
  • Journal Article
  • Randomized Controlled Trial
Form of publication:
  • Journal Article
All authors:
  • Ganz PA, Bandos H, Spanic T, Friedman S, Muller V, Kuemmel S, Delaloge S, Brain E, Toi M, Yamauchi H, de Duenas EM, Armstrong A, Im SA, Song CG, Zheng H, Sarosiek T, Sharma P, Geng C, Fu P, Rhiem K, Frauchiger-Heuer H, Wimberger P, t'Kint de Roodenbeke D, Liao N, Goodwin A, Chakiba-Brugere C, Friedlander M, Lee KS, Giacchetti S, Takano T, Henao-Carrasco F, Virani S, Valdes-Albini F, Domchek SM, Bane C, McCarron EC, Mita M, Rossi G, Rastogi P, Fielding A, Gelber RD, Scheepers ED, Cameron D, Garber J, Geyer CE, Tutt ANJ
21.
What Proportion of BRCA-Associated Breast Cancer Is Human Epidermal Growth Factor 2-Low and Eligible for Additional Targeted Therapy?. MedStar authors:
  • Whitaker, Kristen
PMID:
  • 38776577
Year: 2024
Citation:
  • Journal of Surgical Research. 299:217-223, 2024 Jul.
Institution:
  • MedStar Washington Hospital Center
Department:
  • Hematology/Oncology
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Forester E, Belsare A, Kim DW, Whitaker K, Obeid E, Goldstein LJ, Bleicher RJ, Daly MB, Williams AD
Pages

Powered by Koha